rs199557318

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_001244008.2(KIF1A):​c.4985G>A​(p.Arg1662His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000162 in 1,606,608 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1662C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00024 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

KIF1A
NM_001244008.2 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:2

Conservation

PhyloP100: 2.44

Publications

1 publications found
Variant links:
Genes affected
KIF1A (HGNC:888): (kinesin family member 1A) The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]
KIF1A Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neuropathy, hereditary sensory, type 2C
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • hereditary spastic paraplegia 30
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • PEHO syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.060803175).
BP6
Variant 2-240719810-C-T is Benign according to our data. Variant chr2-240719810-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 464256.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF1ANM_001244008.2 linkc.4985G>A p.Arg1662His missense_variant Exon 46 of 49 ENST00000498729.9 NP_001230937.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF1AENST00000498729.9 linkc.4985G>A p.Arg1662His missense_variant Exon 46 of 49 5 NM_001244008.2 ENSP00000438388.1

Frequencies

GnomAD3 genomes
AF:
0.000236
AC:
36
AN:
152228
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000184
AC:
44
AN:
239574
AF XY:
0.000214
show subpopulations
Gnomad AFR exome
AF:
0.000400
Gnomad AMR exome
AF:
0.000446
Gnomad ASJ exome
AF:
0.00116
Gnomad EAS exome
AF:
0.0000570
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000835
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000155
AC:
225
AN:
1454380
Hom.:
0
Cov.:
30
AF XY:
0.000159
AC XY:
115
AN XY:
723114
show subpopulations
African (AFR)
AF:
0.000391
AC:
13
AN:
33226
American (AMR)
AF:
0.000410
AC:
18
AN:
43944
Ashkenazi Jewish (ASJ)
AF:
0.00117
AC:
30
AN:
25700
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39488
South Asian (SAS)
AF:
0.000106
AC:
9
AN:
85224
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52302
Middle Eastern (MID)
AF:
0.000176
AC:
1
AN:
5686
European-Non Finnish (NFE)
AF:
0.000127
AC:
141
AN:
1108710
Other (OTH)
AF:
0.000200
AC:
12
AN:
60100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000236
AC:
36
AN:
152228
Hom.:
0
Cov.:
33
AF XY:
0.000188
AC XY:
14
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.000386
AC:
16
AN:
41458
American (AMR)
AF:
0.000262
AC:
4
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4838
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000176
AC:
12
AN:
68036
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000342
Hom.:
0
Bravo
AF:
0.000264
ESP6500AA
AF:
0.000252
AC:
1
ESP6500EA
AF:
0.000120
AC:
1
ExAC
AF:
0.000207
AC:
25

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:4
Sep 10, 2020
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 07, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The KIF1A c.4682G>A; p.Arg1561His variant (rs199557318), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 464256). This variant is found in the Ashkenazi Jewish population with an overall allele frequency of 0.11% (11/9766 alleles) in the Genome Aggregation Database. The arginine at codon 1561 is moderately conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. However, given the lack of clinical and functional data, the significance of the p.Arg1561His variant is uncertain at this time. -

Oct 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KIF1A: PP2 -

May 23, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported in the heterozygous state in an adult with hereditary spastic paraplegia (PMID: 32737135); Identified in a healthy parent of an individual with epilepsy and intellectual disability (PMID: 34490037); In silico analysis indicates that this missense variant does not alter protein structure/function; This amino acid substitution does not occur within the predicted motor domain of the protein, where most pathogenic missense variants in KIF1A have been identified (PMID: 25265257); This variant is associated with the following publications: (PMID: 34490037, 32737135, 25265257) -

Hereditary spastic paraplegia 30 Benign:1
Jul 17, 2023
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely benign. Following criteria are met: 0103 - Dominant negative, loss of function and gain of function are known mechanisms of disease in this gene. Variants with a dominant negative effect have been shown to cause NESCAV syndrome (MIM#614255; OMIM). Both loss and gain of function mechanisms have been reported for variants causing spastic paraplegia (MIM#610357, MIM#610357) and hereditary sensory and autonomic neuropathy type 2 (HSAN2; MIM#614213) (PMID: 31488895, 31455732). (I) 0108 - This gene is associated with both recessive and dominant disease. Genotype-phenotype correlation is not currently established. Missense variants tend to cluster within the kinesin motor domain and have been reported for both SPG30 and NESCAV syndrome. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to histidine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 (v2; 57 heterozygotes, 0 homozygotes). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2; 5 heterozygotes, 0 homozygotes). (I) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0808 - Previous reports of pathogenicity for this variant are conflicting. This variant has been classified as a VUS and likely benign in ClinVar. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1206 - Variant has been shown to be paternally inherited. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -

Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Benign:1
Nov 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.31
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.23
T;.;.;.;.;.;.;T;.;.;.;.;.;.
Eigen
Benign
0.080
Eigen_PC
Benign
0.079
FATHMM_MKL
Benign
0.43
N
LIST_S2
Uncertain
0.93
.;D;D;D;D;D;.;D;D;D;D;D;D;D
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.061
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.54
T
MutationAssessor
Uncertain
2.2
M;.;.;.;.;.;.;M;.;.;.;.;.;.
PhyloP100
2.4
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
-2.3
.;N;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
0.11
Sift
Benign
0.10
.;T;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
0.56
.;T;.;.;.;.;.;.;.;.;.;.;.;.
Polyphen
0.95
P;.;.;.;.;.;.;P;.;.;.;.;.;.
Vest4
0.51
MVP
0.73
MPC
1.3
ClinPred
0.043
T
GERP RS
4.1
Varity_R
0.090
gMVP
0.23
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199557318; hg19: chr2-241659227; COSMIC: COSV57502181; COSMIC: COSV57502181; API